English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Litton et al. noted that many of the risk factors for iron deficiency are also risk factors for developing a critical illness, and consequently, iron deficiency is likely to be over-represented in critically ill patients [1]. Hepcidin is described as the master regulator of iron that determines the severity and duration of an iron-restricted state [1]. Insufficient hepcidin levels are central to iron overload while hepcidin excess leads to iron restriction [1]. A persistent state of iron dysmetabolism not only predisposes a vulnerable population to decreased erythropoiesis, but also has implications for the risk of nosocomial infection and critical illness-associated cognitive, neuromuscular, and cardiopulmonary dysfunction [1]. A recent cohort study of 807 critically ill patients with acute kidney injury (AKI) requiring renal replacement therapy (RRT) found that both higher plasma concentrations of catalytic iron and lower concentrations of hepcidin are associated with increased mortality [2]. A key question arising from this study is to what extent RRT contributes to iron dysmetabolism in critically ill patients. Fifty percent of critically ill patients develop AKI and 25% require RRT [3]. Hepcidin and pro-hepcidin have molecular weights of 2700 Da and 10,000 Da, respectively, and, therefore, may be removed by continuous RRT (CRRT), which uses membranes with a cut-off of 35,000 Da [4]. The protein-bound fraction of hepcidin is about 40% [4] which does not impede its elimination by convection or diffusion [5]. It has been demonstrated that

Hepcidin is described as the master regulator of iron: could its removal by CRRT lead to iron dysmetabolism in the critically ill?